ImmunityBio Inc (NASDAQ: IBRX) is -17.97% lower on its value in year-to-date trading and has touched a low of $2.28 and a high of $10.01 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $2.54 in the last trading session, with the day’s loss setting it -0.44%.
Currently trading at $2.10, the stock is -18.29% and -24.85% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 31.02 million and changing -17.32% at the moment leaves the stock -42.53% off its SMA200. IBRX registered -75.41% loss for a year compared to 6-month loss of -62.77%.
The stock witnessed a -29.29% gain in the last 1 month and extending the period to 3 months gives it a -34.38%, and is -20.15% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.98% over the week and 9.53% over the month.
ImmunityBio Inc (IBRX) has around 680 employees, a market worth around $1.85B and $14.74M in sales. Profit margin for the company is -2804.77%. Distance from 52-week low is -7.89% and -79.02% from its 52-week high. The company has generated returns on investments over the last 12 months (-141.63%).
The EPS is expected to grow by 20.97% this year.
ImmunityBio Inc (IBRX) Top Institutional Holders
The shares outstanding are 852.74M, and float is at 91.80M with Short Float at 73.18%.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0135% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6629 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1448% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5703 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
